- Home
- IPHA vs BZUN Comparison
IPHA vs BZUN Comparison
Compare IPHA & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- BZUN
- Stock Information
- Founded
- IPHA 1999
- BZUN 2007
- Country
- IPHA France
- BZUN China
- Employees
- IPHA N/A
- BZUN N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- BZUN Catalog/Specialty Distribution
- Sector
- IPHA Health Care
- BZUN Consumer Discretionary
- Exchange
- IPHA Nasdaq
- BZUN Nasdaq
- Market Cap
- IPHA 160.1M
- BZUN 275.9M
- IPO Year
- IPHA 2019
- BZUN N/A
- Fundamental
- Price
- IPHA $2.05
- BZUN $4.58
- Analyst Decision
- IPHA Strong Buy
- BZUN Strong Buy
- Analyst Count
- IPHA 1
- BZUN 1
- Target Price
- IPHA $11.00
- BZUN $4.20
- AVG Volume (30 Days)
- IPHA 14.6K
- BZUN 735.7K
- Earning Date
- IPHA 09-17-2025
- BZUN 08-28-2025
- Dividend Yield
- IPHA N/A
- BZUN N/A
- EPS Growth
- IPHA N/A
- BZUN N/A
- EPS
- IPHA N/A
- BZUN N/A
- Revenue
- IPHA $14,839,695.00
- BZUN $1,349,630,922.00
- Revenue This Year
- IPHA $350.96
- BZUN $5.27
- Revenue Next Year
- IPHA $32.92
- BZUN $3.46
- P/E Ratio
- IPHA N/A
- BZUN N/A
- Revenue Growth
- IPHA N/A
- BZUN 7.73
- 52 Week Low
- IPHA $1.29
- BZUN $2.12
- 52 Week High
- IPHA $3.51
- BZUN $4.88
- Technical
- Relative Strength Index (RSI)
- IPHA 46.87
- BZUN 70.87
- Support Level
- IPHA $1.93
- BZUN $4.32
- Resistance Level
- IPHA $2.19
- BZUN $4.88
- Average True Range (ATR)
- IPHA 0.11
- BZUN 0.36
- MACD
- IPHA -0.01
- BZUN 0.09
- Stochastic Oscillator
- IPHA 49.66
- BZUN 86.11
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.